|
RNF5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.165170E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.392100E-04 |
| Normal-vs-Stage2 |
9.295600E-02 |
| Normal-vs-Stage3 |
1.824990E-01 |
| Normal-vs-Stage4 |
3.529800E-01 |
| Stage1-vs-Stage2 |
8.373400E-01 |
| Stage1-vs-Stage3 |
3.372200E-01 |
| Stage1-vs-Stage4 |
7.194800E-01 |
| Stage2-vs-Stage3 |
6.278200E-01 |
| Stage2-vs-Stage4 |
8.409400E-01 |
| Stage3-vs-Stage4 |
8.685800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.550700E-04 |
| Normal-vs-AfricanAmerican |
8.479000E-03 |
| Normal-vs-Asian |
1.553640E-01 |
| Caucasian-vs-AfricanAmerican |
5.107600E-01 |
| Caucasian-vs-Asian |
2.329200E-01 |
| AfricanAmerican-vs-Asian |
3.840400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.204900E-04 |
| Normal-vs-Female |
4.750700E-04 |
| Male-vs-Female |
6.064000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.162270E-03 |
| Normal-vs-Extreme_Weight |
2.595400E-04 |
| Normal-vs-Obese |
3.060000E-02 |
| Normal-vs-Extreme_Obese |
1.084590E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.834200E-01 |
| Normal_Weight-vs-Obese |
2.150400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.705600E-01 |
| Extreme_Weight-vs-Obese |
1.636430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.935200E-01 |
| Obese-vs-Extreme_Obese |
8.569600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.77009999999501E-05 |
| Normal-vs-Age(41-60Yrs) |
4.056800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.359540E-04 |
| Normal-vs-Age(81-100Yrs) |
1.780340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.840500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.099950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.505220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.673600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.694800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.081400E-03 |
| Normal-VS-Type2 PRCC |
1.023240E-01 |
| Normal-VS-KIRP CIMP |
1.40139999604827E-08 |
| Normal-VS-Unclassified PRCC |
1.820560E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.687800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.04069999999446E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.035700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.91236000000039E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.378200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.380300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.485870E-02 |
| Normal-vs-N1 |
8.296100E-02 |
| Normal-vs-N2 |
3.94830000000068E-05 |
| N0-vs-N1 |
8.772000E-01 |
| N0-vs-N2 |
2.32089999996354E-06 |
| N1-vs-N2 |
1.803410E-03 |
|
|
